Talecris Biotherapeutics Holdings Corp.
DelistedCIK 1405197fmd_1040CYHMW6SRK9KH09M25C7MFCManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2011, 2 periods
Latest quarter · Q1 FY2011
Millions- Total revenues
- 407
- Gross profit
- 173
- Operating income
- 94
- Net income
- 55
- Free cash flow
- (14)